SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017458
Filing Date
2019-11-14
Accepted
2019-11-14 16:06:27
Documents
52
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 787344
2 ex31-1.htm EX-31.1 12026
3 ex31-2.htm EX-31.2 11789
4 ex32-1.htm EX-32.1 8082
5 ex32-2.htm EX-32.2 8410
  Complete submission text file 0001493152-19-017458.txt   3885493

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ogen-20190930.xml EX-101.INS 832472
7 XBRL SCHEMA FILE ogen-20190930.xsd EX-101.SCH 36346
8 XBRL CALCULATION FILE ogen-20190930_cal.xml EX-101.CAL 40285
9 XBRL DEFINITION FILE ogen-20190930_def.xml EX-101.DEF 147897
10 XBRL LABEL FILE ogen-20190930_lab.xml EX-101.LAB 253649
11 XBRL PRESENTATION FILE ogen-20190930_pre.xml EX-101.PRE 198842
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 191220064
SIC: 2834 Pharmaceutical Preparations